Well, traders aren’t the one who will read the outcome of the trial, it is the fda. FDA won’t listen to AF on his piece. In the end FDA will decide whether this is approve or not. Whatever the share price when tld comes out is only temporary until we get fda bla approval. So why would LP care now if she never cared about the share price before and even now?
Market Data 
Markets 
AI
